Correlation Between Centessa Pharmaceuticals and 69371RR65
Specify exactly 2 symbols:
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and PCAR 2 04 FEB 27, you can compare the effects of market volatilities on Centessa Pharmaceuticals and 69371RR65 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of 69371RR65. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and 69371RR65.
Diversification Opportunities for Centessa Pharmaceuticals and 69371RR65
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Centessa and 69371RR65 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and PCAR 2 04 FEB 27 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PCAR 2 04 and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with 69371RR65. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PCAR 2 04 has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and 69371RR65 go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and 69371RR65
If you would invest 844.00 in Centessa Pharmaceuticals PLC on September 2, 2024 and sell it today you would earn a total of 947.00 from holding Centessa Pharmaceuticals PLC or generate 112.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.79% |
| Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. PCAR 2 04 FEB 27
Performance |
| Timeline |
| Centessa Pharmaceuticals |
| PCAR 2 04 |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Centessa Pharmaceuticals and 69371RR65 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Centessa Pharmaceuticals and 69371RR65
The main advantage of trading using opposite Centessa Pharmaceuticals and 69371RR65 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, 69371RR65 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 69371RR65 will offset losses from the drop in 69371RR65's long position.| Centessa Pharmaceuticals vs. Tff Pharmaceuticals | Centessa Pharmaceuticals vs. Eliem Therapeutics | Centessa Pharmaceuticals vs. Inhibrx | Centessa Pharmaceuticals vs. Enliven Therapeutics |
| 69371RR65 vs. Saia Inc | 69371RR65 vs. Kinetik Holdings | 69371RR65 vs. Old Dominion Freight | 69371RR65 vs. Atmos Energy |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |